
Management ChangeOct 27, 2026, 09:01 AM
Lifeward Ltd. Appoints Ronen Tsimerman as New CFO
AI Summary
Lifeward Ltd. announced the appointment of Ronen Tsimerman as its new Chief Financial Officer, principal financial officer, and principal accounting officer, effective November 1, 2026. Mr. Tsimerman brings extensive experience, having previously held CFO roles at Scopio Labs Ltd. and IceCure Medical Ltd. His employment agreement includes a base salary of NIS 70,000 per month, performance-based bonuses, and a notice period for termination. The appointment is subject to shareholder approval of the company's renewed compensation policy at the upcoming annual general meeting.
Key Highlights
- Ronen Tsimerman appointed Chief Financial Officer, principal financial officer, and principal accounting officer of Lifeward Ltd. effective November 1, 2026.
- Mr. Tsimerman previously served as CFO of Scopio Labs Ltd. and IceCure Medical Ltd.
- The CFO Employment Agreement includes a gross monthly base salary of NIS 70,000, with potential bonuses.
- The agreement also includes a 3-month notice period for termination, increasing to four months under certain conditions.
Price Impact
More from LFWD